BRIACELL THERAPEUTICS CORP. (BCTXL) Operating cash flow 2021–2025
BRIACELL THERAPEUTICS CORP. (BCTXL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.2MFY2025 · since FY2021: -$7.8M → -$28.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.2M | -16.8% |
| FY2024 | -$24.1M | -1.6% |
| FY2023 | -$23.7M | -90.2% |
| FY2022 | -$12.5M | -61.1% |
| FY2021 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice